Effect and safety analysis of immune checkpoint inhibitors (Bevacizumab and Pimumab) combined with nutritional support on survival in patients with DMMR recurrent endometrial cancer
被引:0
作者:
Du, Zhixiang
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R ChinaHebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
Du, Zhixiang
[1
]
Wang, Na
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R ChinaHebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
Wang, Na
[1
]
Wang, Xu
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Obstet, Hosp 1, Shijiazhuang, Hebei, Peoples R ChinaHebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
Wang, Xu
[2
]
Wei, Xurui
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R ChinaHebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
Wei, Xurui
[1
]
Wang, Yujing
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R ChinaHebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
Wang, Yujing
[1
]
机构:
[1] Hebei Med Univ, Dept Gynecol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Obstet, Hosp 1, Shijiazhuang, Hebei, Peoples R China